Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache
Clinical trial NCT03944876 · RECRUITING
Trial details
- NCT number
- NCT03944876
- Sponsor
- Norwegian University of Science and Technology
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2025-09-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.